Farhad Peerani graduated from the University of British Columbia’s medical program and completed residencies in internal medicine and gastroenterology at the University of Alberta. He pursued an advanced two-year clinical research Inflammatory Bowel Disease (IBD) Fellowship at both the University of Alberta and Mount Sinai Hospital in New York City. He was subsequently appointed Assistant Professor of Medicine at the University of Alberta on July 1, 2016 and leads the IBD clinical trials unit. His primary research interests are in real-world effectiveness of biologic therapies, IBD in the elderly and the primary sclerosing cholangitis-IBD phenotype.
- News & Events